New Novartis R&D centre in China
Fabrice Martin
Swiss pharmaceutical lab company Novartis announced its 8th R&D centre in Shanghaï, China.Mainly dedicated to research on infectious causes of prevalent cancers in China, this centre represents a USD 100 million investment. By establishing its new centre, which should employ more than 400 researchers by 2008, at the Zhangjiang Hi-Tech Park, near Shanghaï, Novartis bets on the development of this emerging life science cluster.
Operations are set to begin in May 2007.
More information about ABG?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
Tecknowmetrix
ONERA - The French Aerospace Lab
MabDesign
ASNR - Autorité de sûreté nucléaire et de radioprotection - Siège
PhDOOC
Laboratoire National de Métrologie et d'Essais - LNE
TotalEnergies
CASDEN
Généthon
MabDesign
Aérocentre, Pôle d'excellence régional
Institut Sup'biotech de Paris
ANRT
Groupe AFNOR - Association française de normalisation
ADEME
Nokia Bell Labs France
Ifremer
SUEZ
CESI
-
JobRef. 132742Genève, SwitzerlandEPSU
Professeur de Biologie UP à Genève
Scientific expertises :Biology - Biochemistry - Chemistry
Experience level :Confirmed
-
JobRef. 132696Montreal, CanadaMcGill University
Post-doctoral position in medicinal chemistry
Scientific expertises :Chemistry - Biochemistry
Experience level :Junior